Pituitary ACTH Hypersecretion (Cushing Disease) – Pipeline by Companies 2017-2024
Overview
Cushing’s disease is a condition which results from hypersecretion of adrenocorticotropic hormone (ACTH) due to pituitary gland tumor. Symptoms include acne or skin infections, backache, mental changes (such as depression, anxiety, or changes in behavior), plethora, menstrual disorders and weight gain. Treatment includes radiation, chemotherapy, and use of certain hormone-inhibiting drugs.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2740070-pituitary-acth-hypersecretion-cushing-disease-pipeline-review-h2-2017
Top Companies mentioned
Amryt Pharma plc
Crinetics Pharmaceuticals Inc
Cyclacel Pharmaceuticals Inc
Ipsen SA
Novartis AG
Strongbridge Biopharma plc
Major Highlight
Pharmaceutical and Healthcare latest pipeline guide Pituitary ACTH Hypersecretion - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Pituitary ACTH Hypersecretion , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Pituitary ACTH Hypersecretion (Cushing Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, and Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 1, 2, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Pituitary ACTH Hypersecretion pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2740070-pituitary-acth-hypersecretion-cushing-disease-pipeline-review-h2-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Monday February 26 2018, 6:37 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
